Drug Discovery & Development |
Seattle Gentics-AbbVie Deal Expanded
Zacks.com AbbVie will pay an upfront fee of $25 million for additional rights of using Seattle Genetics’ ADC technology with AbbVie antibodies against oncology targets. Seattle Genetics could receive up to $255 million from AbbVie in the form of potential … Seattle Genetics Further Expands Antibody-Drug Conjugate Collaboration with …Wall Street Journal Seattle Genetics and AbbVie Broaden Cancer PartnershipMotley Fool Seattle Genetics and AbbVie Broaden PartnershipPharmaceutical Processing |
Red Cross extending hours after blood donation shortfall – WEAU
Centralia Fireside guardRed Cross extending hours after blood donation shortfallWEAUEau Claire (WEAU) — The American Red Cross is asking for help after a long run of bad weather hurt blood donations. The organization says it was forced to cancel more …
Antipsychotic drug exhibits cancer-fighting properties – EurekAlert (press release)
|
Antipsychotic drug exhibits cancer-fighting properties
EurekAlert (press release) … results of its pioneering research and clinical trials to patients’ bedsides through five clinical centers: the Blood Disorders Center, the Brain Tumor Center, the Hematologic Malignancies Center, the Solid Tumors Center, and the Stem Cell … |
DCRC cures six blood disorders through stem cell transplant – Gulf Today
CTV News |
DCRC cures six blood disorders through stem cell transplant
Gulf Today DUBAI: The Dubai Cord Blood and Research Centre (DCRC), has succeeded in curing blood disorders in six of its stem cell transplant patients from cord blood. Awareness among parents to donate cord blood to save others’ lives is needed, according to a … BC women can donate umbilical cords to save livesNews1130 BC Women’s Hospital’s umbilical cord blood bank offers gift of lifeVancouver Sun |
Court summons Musharraf on Jan 16 to face treason charges – Chandigarh Tribune
Chandigarh Tribune |
Court summons Musharraf on Jan 16 to face treason charges
Chandigarh Tribune He said the former army chief has not undergone even an angiography since he was admitted to hospital and this proves his condition is not serious. Sheikh claimed Musharraf’s blood pressure was like that of a sportsman while the condition of his heart … Court Rejects Musharraf’s Plea to Stay SummonsOutlook Musharraf’s medical report: A second opinionNewstrack India |
CLL Trial Stopped as Ibrutinib Shows Significant Benefits – Medscape
Medscape |
CLL Trial Stopped as Ibrutinib Shows Significant Benefits
Medscape The only agent so far to have shown an early definitive overall survival benefit in CLL is rituximab (Rituxan, Genentech/Roche), and hence a combination of ibrutinib with rituximab is very appealing — and trials of this combination are in progress … J&J’s Imbruvica tops Arzerra in phase III trialPMLiVE |
What 'Brain-Dead' Means – CBS Local
|
What ‘Brain-Dead’ Means
CBS Local “Typically, brain death starts with some sort of devastating neurologic injury,” Tawil says. “That can come in many different forms.” They include traumatic brain injury, a stroke caused by a ruptured blood vessel in the brain, or if the heart has … |
'Inevitable': As Jahi McMath deteriorates, brain-death case nears end – Los Angeles Times
San Francisco Chronicle |
‘Inevitable’: As Jahi McMath deteriorates, brain-death case nears end
Los Angeles Times Dresser also served on a presidential bioethics council that in 2008 reaffirmed “whole-brain death” as legal death. Brain cells die without blood flow and autopsies in such cases have shown the brain liquefies. In the court declaration filed by Flori … At Issue in 2 Wrenching Cases: What to Do After the Brain DiesNew York Times Case of Jahi McMath raises questions about life after brain deathNBCNews.com (blog) Lawyer: Brain-dead teen Jahi McMath ‘improving’ under ‘optimistic’ doctors’ careCNN KAJ18 Kalispell Montana News –Newsday all 351 news articles » |
A Synthetic Solution Saves Lives – R & D Magazine
R & D Magazine |
A Synthetic Solution Saves Lives
R & D Magazine … a 30-year-old female received a new trachea that was grown using the InBreath bioreactor, created by Harvard Apparatus Regenerative Technology (HART), formerly a division of Harvard Bioscience, marking the first regenerative organ transplant surgery. |
New Drug Combo Might Help Older, Sicker Patients With Leukemia – HealthDay
HealthDayNew Drug Combo Might Help Older, Sicker Patients With LeukemiaHealthDayThe researchers, whose study was funded by the manufacturer of both obinutuzumab and rituximab, reported that the obinutuzumab-chlorambucil combination improved outcomes fo…